1604009

Rifampicina

United States Pharmacopeia (USP) Reference Standard

• Sinónimos: AMP de rifamicina, Rifampina, SV de 3-(4-metilpiperaciniliminometil)rifamicina
• Fórmula empírica (notación de Hill): C₄₃H₅₈N₄O₁₂
• Número de CAS: 13292-46-1
• Peso molecular: 822.94
• Beilstein/REAXYS Number: 5723476
• MDL number: MFCD00151389
• UNSPSC Code: 41116107
• PubChem Substance ID: 329751045
• NACRES: NA.24

Propiedades

• grade: pharmaceutical primary standard
• API family: rifampin
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• storage temp.: 2-8°C
• SMILES string: CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(\C=N\N5CCN(C)CC5)c(O)c4c3C2=O
• InChI: 1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
• InChI key: JQXXHWHPUNPDRT-WLSIYKJHSA-N

Descripción

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Rifampin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Rifampin Capsules
• Rifampin Compounded Oral Suspension
• Rifampin and Isoniazid Capsules
• Rifampin, Isoniazid, and Pyrazinamide Tablets
• Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride Tablets

Biochem/physiol Actions

Inhibe el ensamblaje del ADN y las proteínas en partículas víricas maduras.

Modo de acción: Inhibe la iniciación de la síntesis de ARN al unirse a la subunidad β de la ARN polimerasa.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Información de seguridad

• pictograms: GHS07
• signalword: Warning
• hcodes: H302
• pcodes: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral
• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 1
• flash_point_f: Not applicable
• flash_point_c: Not applicable